Skip to content

Measurement of MSFP and Stressed Volume With CardioQ+®

Measurement of Mean Systemic Filling Pressure & Stressed Volume With CardioQ+® Oesophageal Doppler Measurement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03139929
Enrollment
42
Registered
2017-05-04
Start date
2017-05-09
Completion date
2020-03-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CABG, Cardiac Surgery

Brief summary

To study the reliablity of MSFP and stressed volume to follow volume loading and to predict fload loading responsiveness in patients after elective coronary artery bypass grafting (CABG) surgery.

Detailed description

In this study the oesophageal Doppler monitor (CardioQ+), arterial pulse wave analysis (via the CardioQ+ and Flotrac device) and central venous pressure (CVP) will be used to estimate mean systemic filling pressure (MSFP) with the inspiratory hold method. Furthermore the MSFParm will be determined using a rapid cuff inflator. From MSFP vascular compliance (Csys) and stressed volume (Vs) will be calculated. The accuracy of Vs to follow a 500 increase in volume will be studied. The accuracy of MSFP and Vs to to predict fluid loading responsiveness will be assessed in 42 patients after elective coronary artery bypass grafting (CABG) surgery. The effect of a standardised fluid loading on parameters of intrinsic contractility and afterload will be determined. The effect of fluid loading on inertia, resistance and elastance will be assessed

Interventions

DIAGNOSTIC_TESTMSFP

MSFPhold and MSFParm

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 years and older planned for CABG

Exclusion criteria

* Contraindication for fluid loading * Pregnancy, morbid obesity * Hemodynamic instability with a mean arterial pressure (MAP) \< 55 mm Hg and/ or a cardiac index \< 1.5 L•min-1 * Severe arrhythmias * Intra-cardiac shunts * Symptomatic peripheral vascular disease * Symptomatic pulmonary disease * Significant valvular regurgitation * Poor pre-operative left or right ventricular function * Core temperature \< 36 °C * Contra-indication to the rapid cuff inflator * Contra-indication to oesophageal Doppler probe insertion.

Design outcomes

Primary

MeasureTime frameDescription
MSFPholdBefore and after fluid administration (2 minutes and 10 minutes)Mean systemic filling pressure
MSFParmBefore and after fluid administration (2 minutes and 10 minutes)Mean systemic filling pressure

Secondary

MeasureTime frameDescription
Stressed volumeBefore and after fluid administration (2 minutes and 10 minutes)Vs

Other

MeasureTime frameDescription
SVVBefore and after fluid administration (2 minutes and 10 minutes)stroke volume variation
Vascular compliance (Csys)Before and after fluid administration (2 minutes and 10 minutes)Vascular compliance
Kinetic energyBefore and after fluid administration (2 minutes and 10 minutes)Kinetic energy
CVPBefore and after fluid administration (2 minutes and 10 minutes)central venous pressure
PPVBefore and after fluid administration (2 minutes and 10 minutes)pulse pressure variation

Countries

Netherlands

Contacts

Primary ContactDenise Veelo, MD, PhD
d.p.veelo@amc.uva.nl020 566 9111
Backup ContactAlexander Vlaar, MD, PhD
a.p.vlaar@amc.uva.nl020 566 9111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026